Molecule
NR
Nicotinamide riboside
A NAD+ precursor with a longer safety track record than NMN and the strongest published clinical dataset among consumer NAD+ boosters.
Summary Does NR meaningfully improve health, or only raise NAD+ levels? Show / hide ↓
NR is a supplement ingredient that helps the body make NAD+, a substance cells use for energy and repair. Randomized controlled trials, meaning studies that compare NR with a placebo, show that 300–1000 mg a day reliably raises blood NAD+ levels by about 40–60%. Health benefits are less certain, with modest blood-pressure changes in older adults and possible benefits in some people with Parkinson’s disease, fatty liver disease not caused by alcohol, or high ammonia levels. Studies have not shown convincing anti-aging benefits in healthy adults. NR is generally well tolerated, although high doses can cause mild stomach problems, and product quality varies between brands.
What this means for you: NR reliably raises NAD+ and has a better-established safety and regulatory history than NMN. It may help certain patient groups, but there is not enough evidence that it slows aging or improves health in healthy adults.
moderate evidenceNR was Charles Brenner's original 2004 discovery as a natural NAD+ precursor. It is sold under the Niagen and Tru Niagen brand names, and now in generic forms. It has cleared FDA New Dietary Ingredient (NDI) review, has GRAS status, and has been sold as a supplement in the US, EU, and most other markets for over a decade.
Human data on NR is more extensive than for NMN. Multiple RCTs have shown NR reliably raises blood NAD+ by 40-60% at 300-1000 mg/day. Clinical benefit data: modest improvements in blood pressure in older adults, mild changes in muscle biomarkers, some benefit in specific patient groups (Parkinson's, non-alcoholic fatty liver disease, elevated ammonia levels). No convincing anti-aging endpoint effect in healthy adults.
Whether NR is superior to NMN, inferior, or equivalent is not settled. The main structural argument for NR is that it has cleared regulatory review and has better sourcing quality control. The main argument for NMN is that it is one enzymatic step closer to NAD+, though whether that matters biologically is contested.
Safety is well-characterized. NR is tolerated well, mild GI at high doses. No signal of concern in long-term human use.
Product quality varies. Niagen/Tru Niagen is licensed from ChromaDex and tends to be well-characterized. Generic NR products are more variable.
Products with this: NR
Further reading
Curated external sources for a deeper dive. External links open in a new tab.